Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
Press release
Avignon, January 16th, 2015
31.12.2014
Total number of outstanding shares forming the capital - 9,196,225 ordinary shares under isin FR0000054694 - 362 shares issued from stock-options under ISIN FR0000054694 |
9,196,587 |
Number of shares with double voting rights | 2,044,470 |
Total number of gross voting rights | 11,241,057 |
Number of shares without voting rights - 9,461 bearer shares in the frame of the liquidity contract |
- 9,461 |
Total number of exercisable voting rights* | 11,231,596 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
You can receive all FINANCIAL information of Naturex free of charge by signing up at:
www.naturex.com
- Financial schedule
- Annual revenue- Annual results3 February 2015
31 March 2015
- Upcoming events
- SFAF analysts meeting (Paris) 2 April 2015
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,196,587 (December 2014)
ISIN FR0000054694
NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia, India and Chili. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Thierry-Bertrand Lambert Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.b.lambert@naturex.com |